Professor Carmel Hawley
Professor

Carmel Hawley

Email: 
Phone: 
+61 7 3176 2625

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

712 works between 1965 and 2025
All (712) Journal Article (482) Book Chapter (6) Conference Publication (222) Other Outputs (2)

61 - 80 of 712 works

2023

Journal Article

Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease

Guha, Chandana, Khalid, Rabia, van Zwieten, Anita, Francis, Anna, Hawley, Carmel M., Jauré, Allison, Teixeira-Pinto, Armando, Mallard, Alistair R., Bernier-Jean, Amelie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine M., Ryan, Elizabeth G., Mackie, Fiona, McCarthy, Hugh J., Craig, Jonathan C., Varghese, Julie, Kiriwandeniya, Charani, Howard, Kirsten, Larkins, Nicholas G., Macauley, Luke, Walker, Amanda, Howell, Martin, Irving, Michelle, Caldwell, Patrina H. Y., Woodleigh, Reginald, Jesudason, Shilpanjali, Carter, Simon A. ... Wong, Germaine (2023). Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease. Pediatric Nephrology, 38 (5), 1577-1590. doi: 10.1007/s00467-022-05772-2

Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease

2023

Conference Publication

A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials

Stanley, I., Palma, A., Viecelli, A., Johnson. D., Hawley, C., Staatz, C. and Mallett, A. (2023). A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials. Asian Pacific Society of Dialysis Access (APSDA) Conference, Cairns, QLD Australia, 22-24th October 2023. HOBOKEN: WILEY.

A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials

2023

Journal Article

Characteristics of the gastrointestinal microbiota following prebiotic supplementation in acute kidney transplant recipients: Results from a randomised controlled trial

Chan, Samuel, Wood, David LA, Hawley, Carmel M., Campbell, Katrina L., Campbell, Scott B., Cao, Christopher, Francis, Ross S., Hale, Rachael, Isbel, Nicole M., Pascoe, Elaine M., Johnson, David W. and Morrison, Mark (2023). Characteristics of the gastrointestinal microbiota following prebiotic supplementation in acute kidney transplant recipients: Results from a randomised controlled trial. Clinical Transplantation, 38 (1) e15175, e15175. doi: 10.1111/ctr.15175

Characteristics of the gastrointestinal microbiota following prebiotic supplementation in acute kidney transplant recipients: Results from a randomised controlled trial

2023

Journal Article

Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis

Bek, Sibel G., Marschner, Simone, Sud, Kamal, Johnson, David W., Chow, Clara K., Hawley, Carmel, Pilmore, Helen, Wong, Germaine, Lim, Wai and Lee, Vincent W. (2023). Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis. Nephrology, 28 (1), 21-27. doi: 10.1111/nep.14122

Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis

2022

Journal Article

Approaches to prioritising research for clinical trial networks: a scoping review

Morton, Rachael L., Tuffaha, Haitham, Blaya-Novakova, Vendula, Spencer, Jenean, Hawley, Carmel M., Peyton, Phil, Higgins, Alisa, Marsh, Julie, Taylor, William J., Huckson, Sue, Sillett, Amy, Schneemann, Kieran, Balagurunanthan, Anitha, Cumpston, Miranda, Scuffham, Paul A., Glasziou, Paul and Simes, Robert J. (2022). Approaches to prioritising research for clinical trial networks: a scoping review. Trials, 23 (1) 1000, 1-21. doi: 10.1186/s13063-022-06928-z

Approaches to prioritising research for clinical trial networks: a scoping review

2022

Journal Article

Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation

Pascoe, Elaine M., Chadban, Steven J., Fahim, Magid A., Hawley, Carmel M., Johnson, David W. and Collins, Michael G. (2022). Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation. Trials, 23 (1) 52, 52. doi: 10.1186/s13063-021-05989-w

Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation

2022

Journal Article

Activities supporting the growth of Clinical Trial Networks in Australia

Nemeh, Fiona, Buchbinder, Rachelle, Hawley, Carmel M., Nelson, Mark R., Waterkeyn, Jacqui G. and Reid, Christopher M. (2022). Activities supporting the growth of Clinical Trial Networks in Australia. Trials, 23 (1) 81, 81. doi: 10.1186/s13063-021-05974-3

Activities supporting the growth of Clinical Trial Networks in Australia

2022

Journal Article

Trends in rates of surgery and postoperative mortality among patients receiving chronic kidney replacement therapy: a population-based cohort study

Palamuthusingam, Dharmenaan, Hawley, Carmel M., Pascoe, Elaine M., Johnson, David W., Sivalingam, Palvannan, McDonald, Stephen, Boudville, Neil, Jose, Matthew D., Talaulikar, Girish and Fahim, Magid (2022). Trends in rates of surgery and postoperative mortality among patients receiving chronic kidney replacement therapy: a population-based cohort study. Annals of Surgery, 276 (6), 1002-1010. doi: 10.1097/SLA.0000000000005694

Trends in rates of surgery and postoperative mortality among patients receiving chronic kidney replacement therapy: a population-based cohort study

2022

Journal Article

The authors reply:

Reidlinger, Donna M., Johnson, David W., Craig, Jonathan C., McDonald, Stephen P., Mallard, Alistair R., Robison, Laura E., Wong, Germaine and Hawley, Carmel M. (2022). The authors reply:. Kidney International, 102 (6), 1429-1430. doi: 10.1016/j.kint.2022.10.002

The authors reply:

2022

Journal Article

Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start

Hegerty, Katharine, Jaure, Allison, Scholes-Robertson, Nicole, Howard, Kirsten, Ju, Angela, Evangelidis, Nicole, Wolley, Martin, Baumgart, Amanda, Johnson, David W., Hawley, Carmel, Reidlinger, Donna, Hickey, Laura, Welch, Alyssa, Cho, Yeoungjee, Kerr, Peter G., Roberts, Matthew A., Shen, Jenny I., Craig, Jonathan, Krishnasamy, Rathika, Viecelli, Andrea and on behalf of the INCremental dialysis to improve Health outcomes people starting Hemodialysis (INCH-HD) investigators (2022). Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start. Kidney International Reports, 8 (3), 478-488. doi: 10.1016/j.ekir.2022.11.012

Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start

2022

Journal Article

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

Viecelli, Andrea K., Teixeira-Pinto, Armando, Valks, Andrea, Baer, Richard, Cherian, Roy, Cippà, Pietro E., Craig, Jonathan C., DeSilva, Ranil, Jaure, Allison, Johnson, David W., Kiriwandeniya, Charani, Kopperschmidt, Pascal, Liu, Wen-J, Lee, Timmy, Lok, Charmaine, Madhan, Krishan, Mallard, Alistair R., Oliver, Veronica, Polkinghorne, Kevan R., Quinn, Rob R., Reidlinger, Donna, Roberts, Matthew, Sautenet, Bénédicte, Hooi, Lai Seong, Smith, Rob, Snoeijs, Maarten, Tordoir, Jan, Vachharajani, Tushar J., Vanholder, Raymond ... on behalf of the VALID Investigator Team (2022). Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice. BMC Nephrology, 23 (1) 372, 1-12. doi: 10.1186/s12882-022-02987-1

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

2022

Book Chapter

Dialysis dose and adequacy for hemodialysis

Smyth, Brendan, Hawley, Carmel M. and Jardine, Meg (2022). Dialysis dose and adequacy for hemodialysis. Evidence-based nephrology. (pp. 20-33) edited by Jonathan C. Craig, Donald A. Molony and Giovanni F. M. Strippoli. Hoboken, NJ USA: John Wiley & Sons. doi: 10.1002/9781119105954.ch41

Dialysis dose and adequacy for hemodialysis

2022

Journal Article

Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation

Collins, Michael G., Fahim, Magid A., Pascoe, Elaine M., Hawley, Carmel M., Johnson, David W., Varghese, Julie, Hickey, Laura E., Clayton, Philip A., Gill, John S., Dansie, Kathryn B., McConnochie, Rachael C., Vergara, Liza A., Kiriwandeniya, Charani, Reidlinger, Donna, Mount, Peter F., Weinberg, Laurence, McArthur, Colin J., Toby Coates, P., Endre, Zoltan H., Goodman, David, Howard, Kirsten, Howell, Martin, Jamboti, Jagadish S., Kanellis, John, Laurence, Jerome M., Lim, Wai H., McTaggart, Steven J., O'Connell, Philip J., Pilmore, Helen L. ... on behalf of the BEST-Fluids Investigators and the Australasian Kidney Trials Network (2022). Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation. Transplantation Direct, 8 (12) e1399, 1-13. doi: 10.1097/TXD.0000000000001399

Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation

2022

Conference Publication

Baseline Characteristics and Representativeness of the BEST-Fluids Trial Participants: A Randomized Trial of Balanced Crystalloid Solution vs. Saline in Deceased Donor Kidney Transplantation : PUB312

Collins, Michael G., Fahim, Magid, Pascoe, Elaine, Clayton, Philip A., Hawley, Carmel, Johnson, David W., Dansie, Kathryn, Varghese, Julie A., McConnochie, Rachael C., Robison, Laura, Reidlinger, Donna, Kiriwandeniya, Charani, Chadban, Steven J. and The BEST Fluids Trial Investigators (2022). Baseline Characteristics and Representativeness of the BEST-Fluids Trial Participants: A Randomized Trial of Balanced Crystalloid Solution vs. Saline in Deceased Donor Kidney Transplantation : PUB312. Kidney Week, Philadelphia, PA United States, 1-5 November 2023. Washington, DC United States: American Society of Nephrology. doi: 10.1681/asn.20223311s1971c

Baseline Characteristics and Representativeness of the BEST-Fluids Trial Participants: A Randomized Trial of Balanced Crystalloid Solution vs. Saline in Deceased Donor Kidney Transplantation : PUB312

2022

Conference Publication

Baseline characteristics and representativeness of the BEST-Fluids trial participants: a randomized trial of balanced crystalloid solution vs. saline in deceased donor kidney transplantation

Collins, Michael G., Fahim, Magid, Pascoe, Elaine, Clayton, Philip A., Hawley, Carmel, Johnson, David W., Dansie, Kathryn, Varghese, Julie A., McConnochie, Rachael C., Robison, Laura, Reidlinger, Donna, Kiriwandeniya, Charani and Chadban, Steven J. (2022). Baseline characteristics and representativeness of the BEST-Fluids trial participants: a randomized trial of balanced crystalloid solution vs. saline in deceased donor kidney transplantation. Kidney Week, Orlando, FL USA, 3-6 November 2022. Washington, DC USA: American Society of Nephrology.

Baseline characteristics and representativeness of the BEST-Fluids trial participants: a randomized trial of balanced crystalloid solution vs. saline in deceased donor kidney transplantation

2022

Conference Publication

EXPERIENCES OF PARTICIPANTS ENROLLED IN A RANDOMIZED CONTROLLED TRIAL OF PRESCRIBED WATER INTAKE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

Amin, Sneha, Sangadi, Irene, Saravanabavan, Sayanthooran, Munt, Alexandra, Allman-Farinelli, Margaret, Badve, Sunil, Boudville, Neil, Coolican, Helen, Coulshed, Susan, Foster, Sheryl, Fernando, Mangalee, Haloob, Imad, Harris, David, Hawley, Carmel, Holt, Jane, Howell, Martin, Kumar, Karthik, Johnson, David, Lee, Vincent, Lonergan, Maureen, Mai, Jun, Rangan, Anna, Roger, Simon, Sud, Kamal, Tong, Allison, Torres, Vicente, Vilayur, Eswari and Rangan, Gopala (2022). EXPERIENCES OF PARTICIPANTS ENROLLED IN A RANDOMIZED CONTROLLED TRIAL OF PRESCRIBED WATER INTAKE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. HOBOKEN: WILEY.

EXPERIENCES OF PARTICIPANTS ENROLLED IN A RANDOMIZED CONTROLLED TRIAL OF PRESCRIBED WATER INTAKE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

2022

Conference Publication

PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

Saravanabavan, Sayanthooran, Munt, Alexandra, Badve, Sunil, Boudville, Neil, Coolican, Helen, Coulshed, Susan, Foster, Sheryl, Fernando, Mangalee, Haloob, Imad, Harris, David, Hawley, Carmel, Holt, Jane, Howell, Martin, Kumar, Karthik, Johnson, David, Lee, Vincent, Lonergan, Maureen, Mai, Jun, Roger, Simon, Sud, Kamal, Tong, Allison, Torres, Vicente, Vilayur, Eswari and Rangan, Gopala (2022). PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD). HOBOKEN: WILEY.

PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

2022

Conference Publication

CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE

Krishnasamy, Rathika, Robison, Laura, Howell, Martin, Howard, Kirsten, Reidlinger, Donna, Shenoy, Aparna, Mallard, Alistair, Pascoe, Elaine, Cho, Yeoungjee, Viecelli, Andrea, Roberts, Matthew, Toussaint, Nigel, Badve, Sunil, Peh, Chen Au, Irish, Ashley, Johnson, Davidw and Hawley, Carmel M. (2022). CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE. HOBOKEN: WILEY.

CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE

2022

Conference Publication

Baseline characteristics of participants in the NAVKIDS 2trial: a patient navigator program in children with chronic kidney disease

Guha, Chandana, Khalid, Rabia, Van Zwieten, Anita, Francis, Anna, Hawley, Carmel M., Jaure, Allison, Teixeira-Pinto, Armando, Mallard, Alistair R., Bernier-Jean, Amelie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine M., Ryan, Elizabeth G., Mackie, Fiona, Mccarthy, Hugh J., Craig, Jonathan C., Varghese, Julie, Kiriwandeniya, Charani, Howard, Kirsten, Larkins, Nicholas G., Macauley, Luke, Walker, Amanda, Howell, Martin, Irving, Michelle, Caldwell, Patrina H. Y., Woodleigh, Reginald, Jesudasan, Shilpanjali, Carter, Simon A. ... Wong, Germaine (2022). Baseline characteristics of participants in the NAVKIDS 2trial: a patient navigator program in children with chronic kidney disease. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW Australia, 7-19 October 2022. Richmond, VIC Australia: John Wiley & Sons.

Baseline characteristics of participants in the NAVKIDS 2trial: a patient navigator program in children with chronic kidney disease

2022

Journal Article

Pre-dialysis levels of inflammation and endotoxin in people receiving hemodialysis are not associated with blood pressure variability

Dheda, Shyam, Min, Hongjin, Vesey, David A., Hawley, Carmel, Johnson, David W., Dimeski, Goce, Healy, Helen and Fahim, Magid (2022). Pre-dialysis levels of inflammation and endotoxin in people receiving hemodialysis are not associated with blood pressure variability. Clinical Nephrology, 98 (4), 198-204. doi: 10.5414/CN110656

Pre-dialysis levels of inflammation and endotoxin in people receiving hemodialysis are not associated with blood pressure variability

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2027
    An adaptive, randomised controlled trial to treat polyomavirus infections (BKPyV) in kidney and kidney pancreas transplant recipients (BEAT-BK) trial (MRFF RCRDUN led by USyd)
    University of Sydney
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2020 - 2025
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC CTCS administered by USYD)
    University of Sydney
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au